Astrum Healthcare Revenue and Competitors

Houston, TX USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Astrum Healthcare's estimated annual revenue is currently $7.8M per year.(i)
  • Astrum Healthcare's estimated revenue per employee is $216,000

Employee Data

  • Astrum Healthcare has 36 Employees.(i)
  • Astrum Healthcare grew their employee count by -8% last year.

Astrum Healthcare's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.9M32-9%N/AN/A
#2
$8.6M40-13%N/AN/A
#3
$10.4M4817%N/AN/A
#4
$42.2M14214%N/AN/A
#5
$10.6M4926%N/AN/A
#6
$8M376%N/AN/A
#7
$4M21-5%N/AN/A
#8
$8.9M41-7%N/AN/A
#9
$10.8M500%N/AN/A
#10
$8M37-24%N/AN/A
Add Company

What Is Astrum Healthcare?

Astrum Healthcare is the parent company of Stat-Tox and Astrum Seating and Mobility. Astrum Seating and Mobility is a complex rehab company specializing in custom wheelchairs and DME. Our specialty is workman's comp and skilled nursing clients. We are extremely knowledgeable utilizing the DADS program in Texas and have over 5 years working with this program. With over 90% of our business focused on workman's comp, private pay, and skilled nursing via the DADS program, we are highly responsive with service and repair. Our core products are: Custom Manual Wheelchairs Custom Power Wheelchairs Seating and Positioning Knee Walkers DME Medical Supplies Stat-Tox is a preferred drug and alcohol test provider in the Houston area. We can help you work through the maze of regulations and assist in workforce education, drug testing programs, teen drug testing, DNA testing for paternity and a variety of other lab services. We offer in-house and mobile testing. In addition we can assist with background checks for employees.

keywords:N/A

N/A

Total Funding

36

Number of Employees

$7.8M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.2M3650%N/A
#2
$2.9M366%N/A
#3
$4.2M360%N/A
#4
$4.4M37-5%N/A
#5
$4.3M37-14%N/A